Skip to main content
GYRE filings

Corporate insider profile

Ying Luo Filing Activity

Latest reported as Chief Executive Officer of GYRE THERAPEUTICS, INC. (GYRE).

Purchase filings
0
Reported companies
1
Net open-market value
-$82,927.44
Latest transaction
May 6, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 6, 2026GYRE THERAPEUTICS, INC. (GYRE)Chief Executive OfficerSale10,315$8.04$82,927